Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Pfizer Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Short-term borrowings, including current portion of long-term debt	6,946)	10,350)	2,945)	2,241)	2,703)
Trade accounts payable	5,633)	6,710)	6,809)	5,578)	4,309)
Dividends payable	2,437)	2,372)	2,303)	2,249)	2,162)
Income taxes payable	2,910)	2,349)	1,587)	1,266)	1,049)
Accrued compensation and related items	3,838)	2,776)	3,407)	3,332)	3,058)
Deferred revenues	1,511)	2,700)	2,520)	3,067)	1,113)
Other current liabilities	19,720)	20,537)	22,567)	24,938)	11,526)
Current liabilities	42,995)	47,794)	42,138)	42,671)	25,920)
Long-term debt, excluding current portion	57,405)	61,538)	32,884)	36,195)	37,133)
Pension and postretirement benefit obligations	2,115)	2,167)	2,250)	3,724)	5,411)
Noncurrent deferred tax liabilities	2,122)	640)	1,023)	349)	4,063)
Other taxes payable	6,112)	8,534)	9,812)	11,331)	11,560)
Other noncurrent liabilities	14,150)	16,540)	13,181)	9,743)	6,669)
Noncurrent liabilities	81,904)	89,419)	59,150)	61,342)	64,836)
Total liabilities	124,899)	137,213)	101,288)	104,013)	90,756)
Common stock, $0.05 par value	480)	478)	476)	473)	470)
Additional paid-in capital	93,603)	92,631)	91,802)	90,591)	88,674)
Treasury stock, shares at cost	(114,763)	(114,487)	(113,969)	(111,360)	(110,988)
Retained earnings	116,725)	118,353)	125,656)	103,394)	96,770)
Accumulated other comprehensive loss	(7,842)	(7,961)	(8,304)	(5,897)	(11,688)
Total Pfizer Inc. shareholders’ equity	88,203)	89,014)	95,661)	77,201)	63,238)
Equity attributable to noncontrolling interests	294)	274)	255)	261)	235)
Total equity	88,497)	89,288)	95,916)	77,462)	63,473)
Total liabilities and equity	213,396)	226,501)	197,204)	181,475)	154,229)

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Pfizer Inc. current liabilities increased from 2022 to 2023 but then slightly decreased from 2023 to 2024 not reaching 2022 level.
Noncurrent liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Pfizer Inc. noncurrent liabilities increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Pfizer Inc. total liabilities increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.
Total Pfizer Inc. shareholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Pfizer Inc. total Pfizer Inc. shareholders’ equity decreased from 2022 to 2023 and from 2023 to 2024.

Pfizer Inc. (NYSE:PFE)

Balance Sheet: Liabilities and Stockholders’ Equity